세계의 페니실린 시장 - 산업규모, 점유율, 동향, 기회 및 예측, 제품별, 유형별, 투여경로별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Penicillin Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Type, By Route of Administration, By End User, By Region & Competition, 2020-2030F
상품코드:1732856
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
페니실린 세계 시장은 2024년에 101억 5,000만 달러로 평가되었으며, 2030년에는 125억 8,000만 달러에 이르고, CAGR 3.60%로 성장할 것으로 예측됩니다.
페니실린은 약 1세기 전에 발견되었음에도 불구하고, 그 폭넓은 스펙트럼 활성, 비용 효과, 영구적인 임상적 유용성에 의해 항균 치료의 요점으로 계속되고 있습니다. 신약과의 경쟁과 같은 장애물에 직면하고 있는 것, 특히 신흥국 지역에서의 헬스케어 인프라의 확대, 인구동태의 변화, 약제제제나 딜리버리 메커니즘의 지속적인 진보에 의해 지원되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
101억 5,000만 달러
시장 규모 : 2030년
125억 8,000만 달러
CAGR : 2025-2030년
3.60%
급성장 부문
베타 락타마제 억제제
최대 시장
북미
시장 성장 촉진요인
세균 감염률 상승
주요 시장 과제
항생제 내성과 박테리아 균주의 진화
주요 시장 동향
드래그 제형 및 전달 방법의 혁신
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 페니실린 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
제품별(벌크, 용량)
유형별(아미노페니실린, 항녹농균 페니실린, β락타마제 억제제, 기타)
투여경로(경구, 근육내, 정맥내)
최종사용자별(병원 및 클리닉, 제약 및 바이오테크놀러지 기업, 학술기관 및 연구기관)
지역별
기업별(2024년)
시장 맵
제6장 북미 페니실린 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽 페니실린 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양 페니실린 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미 페니실린 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카 페니실린 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
합병과 인수
제13장 세계의 페니실린 시장 : SWOT 분석
제14장 경쟁 구도
Astellas Pharma Inc.
Novartis International AG
GlaxoSmithKline plc
Pfizer Inc.
Merck Co. & Inc.
F.Hoffmann-La Roche Ltd.
Toyama Chemical Co., Ltd.
Sanofi Aventis SA
MiddleBrook Pharmaceuticals, Inc.
Gilead Sciences Inc.
제15장 전략적 제안
제16장 기업 소개와 면책사항
SHW
영문 목차
영문목차
The Global Penicillin Market was valued at USD 10.15 Billion in 2024 and is projected to reach USD 12.58 Billion by 2030, growing at a CAGR of 3.60%. Despite its discovery nearly a century ago, penicillin remains a cornerstone of antibacterial therapy due to its broad-spectrum activity, cost-effectiveness, and enduring clinical utility. Its demand continues to be strong worldwide, driven by its therapeutic efficacy and affordability, particularly in treating various bacterial infections. Although the market faces hurdles such as rising antimicrobial resistance and competition from newer drugs, it is bolstered by expanding healthcare infrastructure, especially in developing regions, demographic shifts, and continuous advancements in drug formulations and delivery mechanisms. These dynamics collectively support the long-term growth and strategic importance of penicillin in the global antibiotic landscape.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 10.15 Billion
Market Size 2030
USD 12.58 Billion
CAGR 2025-2030
3.60%
Fastest Growing Segment
Beta-Lactamase Inhibitor
Largest Market
North America
Key Market Drivers
Rising Prevalence of Bacterial Infections
The increasing incidence of bacterial infections significantly propels the growth of the Global Penicillin Market. A recent global health review found that bacterial infections, excluding tuberculosis, accounted for 7.7 million deaths worldwide-13.6% of all deaths-underscoring the critical need for effective antibiotics. Penicillin remains a primary treatment for various infections including respiratory tract conditions like pneumonia and bronchitis, skin and soft tissue infections, UTIs, streptococcal and staphylococcal infections, and STDs such as syphilis. These infections are particularly widespread in low- and middle-income countries, where access to clean water, sanitation, and healthcare is limited. Given its effectiveness against many such pathogens, penicillin's demand continues to rise in alignment with global infection rates.
Key Market Challenges
Antibiotic Resistance and Evolving Bacterial Strains
The escalating issue of antibiotic resistance represents a major challenge to the penicillin market. Misuse and overuse of antibiotics have led to resistant strains like Penicillin-resistant Streptococcus pneumoniae and MRSA, reducing the drug's effectiveness. This has compelled healthcare professionals to opt for more advanced and often costlier antibiotics. In turn, this shift impacts penicillin's market share and has led to stricter regulatory measures and antibiotic stewardship programs aimed at curbing inappropriate prescriptions, thereby restraining market growth.
Key Market Trends
Innovation in Drug Formulations and Delivery Methods
The penicillin market is experiencing growth through advancements in drug formulations and delivery systems. Novel developments like extended-release injectables, child-friendly suspensions, and combination therapies are enhancing patient adherence, broadening clinical applications, and minimizing side effects. These innovations are critical in maintaining penicillin's relevance against rising resistance, improving therapeutic outcomes, and opening up new segments, including neonatal and elderly care, thus driving further market expansion.
Key Market Players
Astellas Pharma Inc.
Novartis International AG
GlaxoSmithKline plc
Pfizer Inc.
Merck Co. & Inc.
F.Hoffmann-La Roche Ltd.
Toyama Chemical Co., Ltd.
Sanofi Aventis SA
MiddleBrook Pharmaceuticals, Inc.
Gilead Sciences Inc
Report Scope:
In this report, the Global Penicillin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Penicillin Market, By Product:
Bulk
Dosage
Penicillin Market, By Type:
Aminopenicillin
Antipseudomonal Penicillin
Beta Lactamase Inhibitor
Others
Penicillin Market, By Route of Administration:
Oral
Intramuscular
Intravenous
Penicillin Market, By End User:
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Academic & Research Institutions
Penicillin Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Penicillin Market.
Available Customizations:
Global Penicillin market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Penicillin Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Bulk, Dosage)
5.2.2. By Type (Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, Others)
5.2.3. By Route of Administration (Oral, Intramuscular, Intravenous)
5.2.4. By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Penicillin Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Type
6.2.3. By Route of Administration
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Penicillin Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Type
6.3.1.2.3. By Route of Administration
6.3.1.2.4. By End User
6.3.2. Canada Penicillin Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Type
6.3.2.2.3. By Route of Administration
6.3.2.2.4. By End User
6.3.3. Mexico Penicillin Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Type
6.3.3.2.3. By Route of Administration
6.3.3.2.4. By End User
7. Europe Penicillin Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Type
7.2.3. By Route of Administration
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Penicillin Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Type
7.3.1.2.3. By Route of Administration
7.3.1.2.4. By End User
7.3.2. United Kingdom Penicillin Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Type
7.3.2.2.3. By Route of Administration
7.3.2.2.4. By End User
7.3.3. Italy Penicillin Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Type
7.3.3.2.3. By Route of Administration
7.3.3.2.4. By End User
7.3.4. France Penicillin Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Type
7.3.4.2.3. By Route of Administration
7.3.4.2.4. By End User
7.3.5. Spain Penicillin Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Type
7.3.5.2.3. By Route of Administration
7.3.5.2.4. By End User
8. Asia-Pacific Penicillin Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Type
8.2.3. By Route of Administration
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Penicillin Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Type
8.3.1.2.3. By Route of Administration
8.3.1.2.4. By End User
8.3.2. India Penicillin Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Type
8.3.2.2.3. By Route of Administration
8.3.2.2.4. By End User
8.3.3. Japan Penicillin Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Type
8.3.3.2.3. By Route of Administration
8.3.3.2.4. By End User
8.3.4. South Korea Penicillin Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Type
8.3.4.2.3. By Route of Administration
8.3.4.2.4. By End User
8.3.5. Australia Penicillin Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Type
8.3.5.2.3. By Route of Administration
8.3.5.2.4. By End User
9. South America Penicillin Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Type
9.2.3. By Route of Administration
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Penicillin Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Type
9.3.1.2.3. By Route of Administration
9.3.1.2.4. By End User
9.3.2. Argentina Penicillin Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Type
9.3.2.2.3. By Route of Administration
9.3.2.2.4. By End User
9.3.3. Colombia Penicillin Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Type
9.3.3.2.3. By Route of Administration
9.3.3.2.4. By End User
10. Middle East and Africa Penicillin Market Outlook
